File Name: breathlessness cough and sputum scale .zip
Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI:
- Chronic obstructive pulmonary disease
- COSMIN database
- Use of the Breathlessness, Cough, and Sputum Scale (BCSS©) in Pulmonary Rehabilitation§
Manual chest physiotherapy MCP techniques involving chest percussion, vibration, and shaking have long been used in the treatment of respiratory conditions. However, methodological limitations in existing research have led to a state of clinical equipoise with respect to this treatment. We standardised the delivery of MCP and assessed its effectiveness on disease-specific quality of life. In this randomised, controlled trial powered for equivalence, patients hospitalised with acute COPD exacerbation were enrolled from four centres in the UK. Patients were allocated to receive MCP plus advice on airway clearance or advice on chest clearance alone.
Chronic obstructive pulmonary disease
Breathlessness, cough and sputum scale bcss how much difficulty did you have breathing today. Use of the breathlessness, cough, and sputum scale bcss in. Pdf use of the breathlessness, cough, and sputum scale bcss. The breathlessness, cough and sputum scale bcss is a patientreported outcome measure to evaluate symptoms in patients with chronic obstructive pulmonary disease copd. Rehabilitation, quality of life, dyspnea, cough, sputum.
Chronic obstructive pulmonary disease COPD is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The most common cause of COPD is tobacco smoking , with a smaller number of cases due to factors such as air pollution and genetics. Most cases of COPD can be prevented by reducing exposure to risk factors. As of , COPD affected about The most common symptoms of COPD are shortness of breath , and a cough that produces sputum. A chronic cough is often the first symptom to develop.
Breathlessness, Cough and Sputum Scale (BCSS). HOW MUCH DIFFICULTY DID YOU HAVE BREATHING TODAY? 0 = None – unaware of.
Use of the Breathlessness, Cough, and Sputum Scale (BCSS©) in Pulmonary Rehabilitation§
Toggle navigation Home Bookmarks 0 History Login. Cosmin Website Database of systematic reviews of outcome measurement instruments. Abstract: Background: Conflicting results about the effects of community-based pulmonary rehabilitation in acute exacerbations of chronic obstructive pulmonary disease AECOPD exist, possibly because the variety of outcome measures used and the lack of appropriate measurement properties hinder the development of pulmonary rehabilitation guidelines. Purpose: The purpose of this study was to identify and review the measurement properties of patient-reported outcome measures PROMs and clinical outcome measures of AECOPD that are used in pulmonary rehabilitation and that can be easily applied in a community setting.
Spirometry is a tool that plays an important role in chronic obstructive pulmonary disease COPD — from the moment your doctor thinks you have COPD all the way through its treatment and management. Spirometry can detect COPD even in its earliest stage, even before any obvious symptoms are noticeable. Along with diagnosing COPD, this test can also help track progression of the disease, assist in staging, and even help to determine treatments that might be most effective. This device measures your lung function and records the results, which are also displayed on a graph.
The breathlessness, cough and sputum scale BCSS is a three-item questionnaire rating breathlessness, cough and sputum on a 5-point Likert scale from 0 no symptoms to 4 severe symptoms. Researchers have explored the utility of this tool to quantify efficacy of treatment following a chronic obstructive pulmonary disease COPD exacerbation; however, little work has been done to investigate the ability of the BCSS to predict COPD exacerbation. As part of a prospective case-crossover study among a cohort of COPD patients residing in central Massachusetts, patients were asked standard BCSS questions during exacerbation and randomly identified non-exacerbation or healthy weeks.